| scholarly article | Q13442814 |
| P50 | author | Laura Santambrogio | Q30112066 |
| Cedric S Raine | Q96067895 | ||
| P2093 | author name string | Sergio A Lira | |
| Sarah E Lutz | |||
| Kakuri M Omari | |||
| P2860 | cites work | Regulation of chemokine receptor expression in human microglia and astrocytes | Q28181079 |
| The chemokine receptor CXCR2 controls positioning of oligodendrocyte precursors in developing spinal cord by arresting their migration | Q28217744 | ||
| Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion | Q28253124 | ||
| CC chemokine receptor 2 is critical for induction of experimental autoimmune encephalomyelitis | Q28587371 | ||
| Absence of monocyte chemoattractant protein 1 in mice leads to decreased local macrophage recruitment and antigen-specific T helper cell type 1 immune response in experimental autoimmune encephalomyelitis | Q28755978 | ||
| Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination | Q29614990 | ||
| Multiple sclerosis | Q29616022 | ||
| Chemokines and chemokine receptors in inflammation of the nervous system: manifold roles and exquisite regulation. | Q34118817 | ||
| Why does remyelination fail in multiple sclerosis? | Q34147437 | ||
| Neutrophil infiltration, glial reaction, and neurological disease in transgenic mice expressing the chemokine N51/KC in oligodendrocytes | Q34392185 | ||
| Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions | Q34549857 | ||
| Remyelination can be extensive in multiple sclerosis despite a long disease course | Q34578773 | ||
| Experimental autoimmune encephalomyelitis (EAE) in CCR2(-/-) mice: susceptibility in multiple strains | Q35748862 | ||
| Role for CXCR2 and CXCL1 on glia in multiple sclerosis | Q81020127 | ||
| Immunology of multiple sclerosis | Q81531267 | ||
| CXC chemokine ligand 13 plays a role in experimental autoimmune encephalomyelitis | Q83918246 | ||
| CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. | Q35763957 | ||
| Chemokines and glial cells: a complex network in the central nervous system. | Q35771258 | ||
| CCR1+/CCR5+ mononuclear phagocytes accumulate in the central nervous system of patients with multiple sclerosis. | Q35788387 | ||
| Resistance to experimental autoimmune encephalomyelitis in mice lacking the CC chemokine receptor (CCR)2. | Q36368947 | ||
| Multiple sclerosis: Fas signaling in oligodendrocyte cell death | Q36377383 | ||
| CCR5(+) and CXCR3(+) T cells are increased in multiple sclerosis and their ligands MIP-1alpha and IP-10 are expressed in demyelinating brain lesions | Q36384816 | ||
| Multiple sclerosis--the plaque and its pathogenesis | Q36410882 | ||
| The Th17-ELR+ CXC chemokine pathway is essential for the development of central nervous system autoimmune disease | Q36537921 | ||
| Remyelination is extensive in a subset of multiple sclerosis patients. | Q40295868 | ||
| NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. | Q40750602 | ||
| Expression of the chemokine receptors CXCR1 and CXCR2 in rat oligodendroglial cells | Q40805719 | ||
| Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons | Q40877325 | ||
| Astrocytes produce dendritic cell-attracting chemokines in vitro and in multiple sclerosis lesions | Q42665157 | ||
| CXCR3 expression in human central nervous system diseases. | Q43843160 | ||
| Induction of the CXCL1 (KC) chemokine in mouse astrocytes by infection with the murine encephalomyelitis virus of Theiler | Q45411917 | ||
| Experimental autoimmune encephalomyelitis. Augmentation of demyelination by different myelin lipids | Q46630235 | ||
| Multiple sclerosis: oligodendrocytes display cell death-related molecules in situ but do not undergo apoptosis | Q48048028 | ||
| Multiple sclerosis: cytokine receptors on oligodendrocytes predict innate regulation | Q48101693 | ||
| GRO-alpha and CXCR2 in the human fetal brain and multiple sclerosis lesions | Q48201731 | ||
| Oligodendrocyte progenitors are present in the normal adult human CNS and in the lesions of multiple sclerosis | Q48316974 | ||
| Co-expression of PDGF alpha receptor and NG2 by oligodendrocyte precursors in human CNS and multiple sclerosis lesions. | Q48510365 | ||
| Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia | Q48573807 | ||
| Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis | Q48612585 | ||
| Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment | Q48701331 | ||
| CXC chemokine receptors on human oligodendrocytes: implications for multiple sclerosis. | Q48962767 | ||
| A role for CXCR4 signaling in survival and migration of neural and oligodendrocyte precursors | Q48983632 | ||
| Intracerebral expression of CXCL13 and BAFF is accompanied by formation of lymphoid follicle-like structures in the meninges of mice with relapsing experimental autoimmune encephalomyelitis. | Q51027456 | ||
| Transcription factor co-expression patterns indicate heterogeneity of oligodendroglial subpopulations in adult spinal cord. | Q52018890 | ||
| CXCL10 (IFN-gamma-inducible protein-10) control of encephalitogenic CD4+ T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis. | Q52019458 | ||
| Oligodendrocyte precursor cells in the demyelinated multiple sclerosis spinal cord. | Q52046430 | ||
| Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. | Q52126480 | ||
| The chemokine growth-regulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. | Q52181496 | ||
| Disruption of neutrophil migration in a conditional transgenic model: evidence for CXCR2 desensitization in vivo. | Q52544718 | ||
| Oligodendrocyte precursor cells express a functional chemokine receptor CCR3: implications for myelination. | Q54593114 | ||
| Induction of experimental autoimmune encephalomyelitis in C57BL/6 mice deficient in either the chemokine macrophage inflammatory protein-1alpha or its CCR5 receptor | Q57042424 | ||
| CXCR3 Signaling Reduces the Severity of Experimental Autoimmune Encephalomyelitis by Controlling the Parenchymal Distribution of Effector and Regulatory T Cells in the Central Nervous System | Q57209761 | ||
| Multiple sclerosis: remyelination of nascent lesions | Q70564751 | ||
| Multiple sclerosis. Oligodendrocyte survival and proliferation in an active established lesion | Q71048500 | ||
| An important role for the chemokine macrophage inflammatory protein-1 alpha in the pathogenesis of the T cell-mediated autoimmune disease, experimental autoimmune encephalomyelitis | Q71829114 | ||
| Multiple sclerosis: remyelination in acute lesions | Q72080198 | ||
| Elevated levels of the chemokine GRO-1 correlate with elevated oligodendrocyte progenitor proliferation in the jimpy mutant | Q73575620 | ||
| Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions | Q73855301 | ||
| Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue | Q74016845 | ||
| Platelet-derived growth factor-alpha receptor-positive oligodendroglia are frequent in multiple sclerosis lesions | Q74029926 | ||
| Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid | Q74446414 | ||
| Treatment with anti-granulocyte antibodies inhibits the effector phase of experimental autoimmune encephalomyelitis | Q77620250 | ||
| Transgenic expression of CCL2 in the central nervous system prevents experimental autoimmune encephalomyelitis | Q80992042 | ||
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 164-76 | |
| P577 | publication date | 2009-01-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Neuroprotection and remyelination after autoimmune demyelination in mice that inducibly overexpress CXCL1 | |
| P478 | volume | 174 |
| Q28546579 | Alterations in Brain Inflammation, Synaptic Proteins, and Adult Hippocampal Neurogenesis during Epileptogenesis in Mice Lacking Synapsin2 |
| Q28540312 | An anti-interleukin-2 receptor drug attenuates T- helper 1 lymphocytes-mediated inflammation in an acute model of endotoxin-induced uveitis |
| Q61444780 | Analogues of ERβ ligand chloroindazole exert immunomodulatory and remyelinating effects in a mouse model of multiple sclerosis |
| Q59137473 | Anti-drug Antibodies Against a Novel Humanized Anti-CD20 Antibody Impair Its Therapeutic Effect on Primary Biliary Cholangitis in Human CD20- and FcγR-Expressing Mice |
| Q36428721 | Astrocyte TNFR2 is required for CXCL12-mediated regulation of oligodendrocyte progenitor proliferation and differentiation within the adult CNS. |
| Q83133896 | Astrocyte proximity modulates the myelination gene fabric of oligodendrocytes |
| Q39047793 | Astrocyte-specific activation of TNFR2 promotes oligodendrocyte maturation by secretion of leukemia inhibitory factor |
| Q39146141 | Attempts to Overcome Remyelination Failure: Toward Opening New Therapeutic Avenues for Multiple Sclerosis. |
| Q55264893 | BCG and Adverse Events in the Context of Leprosy. |
| Q55412994 | Bevacizumab Diminishes Inflammation in an Acute Endotoxin-Induced Uveitis Model. |
| Q41360196 | CXCL1 can be regulated by IL-6 and promotes granulocyte adhesion to brain capillaries during bacterial toxin exposure and encephalomyelitis |
| Q35947646 | CXCR2 signaling and host defense following coronavirus-induced encephalomyelitis |
| Q33623734 | CXCR2 signaling protects oligodendrocytes and restricts demyelination in a mouse model of viral-induced demyelination |
| Q27007078 | Chemokine receptor CXCR2: physiology regulator and neuroinflammation controller? |
| Q37455497 | Chemokines and chemokine receptors: standing at the crossroads of immunobiology and neurobiology |
| Q34038312 | Chemokines and inflammatory mediators interact to regulate adult murine neural precursor cell proliferation, survival and differentiation |
| Q38018862 | Chemokines in CNS injury and repair |
| Q42594603 | Class 3 semaphorins influence oligodendrocyte precursor recruitment and remyelination in adult central nervous system |
| Q37370067 | Comparative multiplex analysis of cytokines, chemokines and growth factors in follicular fluid of normoresponder women undergoing ovum donation with gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist protocols |
| Q57808694 | Different roles of CXCR1 and CXCR2 in HTLV-1 carriers and HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients |
| Q93051902 | Disrupted CXCR2 Signaling in Oligodendroglia Lineage Cells Enhances Myelin Repair in a Viral Model of Multiple Sclerosis |
| Q33767086 | ELR(+) chemokine signaling in host defense and disease in a viral model of central nervous system disease |
| Q42939723 | Early postnatal exposure to intermittent hypoxia in rodents is proinflammatory, impairs white matter integrity, and alters brain metabolism |
| Q49218341 | Effects of Keratinocyte-Derived Cytokine (CXCL-1) on the Development of Theiler's Virus-Induced Demyelinating Disease |
| Q47101911 | Epinephrine stimulates CXCL1 IL-1α, IL-6 secretion in isolated mouse limb muscle. |
| Q34796355 | Estrogen-induced protection against experimental autoimmune encephalomyelitis is abrogated in the absence of B cells |
| Q51382068 | Exercise-induced liver chemokine CXCL-1 expression is linked to muscle-derived interleukin-6 expression. |
| Q37967602 | Genetic approaches to study glial cells in the rodent brain. |
| Q39150505 | In vivo immune interactions of multipotent stromal cells underlie their long-lasting pain-relieving effect |
| Q55197700 | Increase in chemokine CXCL1 by ERβ ligand treatment is a key mediator in promoting axon myelination. |
| Q52561535 | Induced CNS expression of CXCL1 augments neurologic disease in a murine model of multiple sclerosis via enhanced neutrophil recruitment. |
| Q37386441 | Inhibition of CXCR2 signaling promotes recovery in models of multiple sclerosis |
| Q37530795 | Innate immune activation in the pathogenesis of a murine model of globoid cell leukodystrophy |
| Q91916968 | LXRs regulate features of age-related macular degeneration and may be a potential therapeutic target |
| Q35173135 | Mediators of oligodendrocyte differentiation during remyelination |
| Q37776054 | Multiple sclerosis and cerebral endothelial dysfunction: Mechanisms |
| Q40098698 | MyD88 contribution to ocular surface homeostasis |
| Q37684330 | Neutralizing endogenous chemokines with small molecules. Principles and potential therapeutic applications. |
| Q48959477 | Oestrogen-mediated protection of experimental autoimmune encephalomyelitis in the absence of Foxp3+ regulatory T cells implicates compensatory pathways including regulatory B cells |
| Q21129352 | Oligodendrogenesis in the normal and pathological central nervous system |
| Q37174777 | On the occurrence of hypomyelination in a transgenic mouse model: a consequence of the myelin basic protein promoter? |
| Q40151204 | Pepsin-pancreatin protein hydrolysates from extruded amaranth inhibit markers of atherosclerosis in LPS-induced THP-1 macrophages-like human cells by reducing expression of proteins in LOX-1 signaling pathway |
| Q92129018 | Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potential |
| Q27010398 | Promoting remyelination in multiple sclerosis-recent advances |
| Q84409628 | Quantification of oligodendrocyte progenitor cells in human and cat optic nerve: implications for endogenous repair in multiple sclerosis |
| Q35083357 | Secretome analysis of human oligodendrocytes derived from neural stem cells |
| Q61816849 | Short and Long-Term Changes in Social Odor Recognition and Plasma Cytokine Levels Following Oxygen (O) Ion Radiation Exposure |
| Q28741063 | Sphingosine kinase 1 and sphingosine 1-phosphate receptor 3 are functionally upregulated on astrocytes under pro-inflammatory conditions |
| Q36362639 | Subcutaneous Transplantation of Neural Precursor Cells in Experimental Autoimmune Encephalomyelitis Reduces Chemotactic Signals in the Central Nervous System |
| Q26781639 | Systematic Review of the Neurobiological Relevance of Chemokines to Psychiatric Disorders |
| Q47908168 | The Subventricular Zone: A Key Player in Human Neocortical Development. |
| Q36468266 | The chemokine receptor CXCR2 and coronavirus-induced neurologic disease |
| Q92213495 | The contribution of astrocytes to the neuroinflammatory response in multiple sclerosis and experimental autoimmune encephalomyelitis |
| Q50939075 | The cre-inducer doxycycline lowers cytokine and chemokine transcript levels in the gut of mice. |
| Q43442018 | The dual role of CXCL8 in human CNS stem cell function: multipotent neural stem cell death and oligodendrocyte progenitor cell chemotaxis |
| Q34570969 | The role of Ifng in alterations in liver gene expression in a mouse model of fulminant autoimmune hepatitis |
| Q33857981 | What's normal? Immune profiling of human milk from healthy women living in different geographical and socioeconomic settings |
Search more.